Stock Market Today, June: Bio-Techne Surges on Merck Bid
A high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
Glide path describes how a target date fund changes its asset mix as the target year approaches, balancing risk and growth for your retirement.
25,488 articlesA high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
Is IonQ stock overvalued right? This in-depth guide breaks down the technology, market timing, and financials to help...
An investment idea rarely makes headlines for decades, yet one ETF has repeatedly outpaced the S&P 500. Learn how equ...
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...
GM is navigating a tepid U.S. EV market, yet the company is pivoting toward energy storage and software. This article...
Dell Technologies has surged on AI demand, pushing year-to-date gains toward 230% as investors bet the hardware giant...
A retirement wave, not automation, is tightening the U.S. labor pool. This piece explains how aging workers impact So...
Healthcare costs loom large for retirees and investors alike. This article argues that one AI-driven healthcare leade...
Bitcoin has seen shifts in on-chain dynamics that suggest selling pressure may be easing. Yet large holders continue ...
Palantir sits around $130 as Michael Burry’s $46 valuation challenge re-emerges, forcing a sharper look at growth, ma...
Investor confidence is up—what’s making headlines? This article breaks down the forces behind a sunnier mood, what it...
Stratasys has long been a trailblazer in 3D printing, but the road ahead is proving tougher amid competition and cost...